Table 1 Comparison of demographic and preoperative data
ANH (n = 25) | Non-ANH (n = 35) | P value | |
|---|---|---|---|
Age (year) | 48.5 ± 16.2 | 49.1 ± 13.9 | 0.873 |
Male, % | 14 (56%) | 24 (68.6%) | 0.319 |
Body mass index | 22.8 ± 2.8 | 23.7 ± 3.5 | 0.289 |
Hypertension, % | 7 (28%) | 6 (17.1%) | 0.314 |
ASA classification, % | |||
1 | 3 (12%) | 6 (17.1%) | 0.863 |
2 | 21 (84%) | 28 (80%) | |
3 | 1 (4%) | 1 (2.9%) | |
Glioblastoma characteristics | |||
Left, % | 8 (32%) | 17 (48.6%) | 0.199 |
Recurrence glioblastoma, % | 3 (12%) | 5 (14.3%) | 0.797 |
Deep location, % | 13 (52%) | 12 (34.3%) | 0.170 |
Tumor size (cm) | 4.9 ± 1.7 | 5.0 ± 2.3 | 0.937 |
Preoperative laboratory studies | |||
Hemoglobin (g/dL) | 13.9 ± 1.7 | 13.9 ± 1.4 | 0.967 |
Platelet count (K/μL) | 248.4 ± 70.7 | 221.5 ± 57.0 | 0.107 |
INR | 1.03 ± 0.09 | 1.00 ± 0.07 | 0.152 |
PT (s) | 12.6 ± 1.1 | 12.1 ± 0.9 | 0.107 |
APTT (s) | 32.8 ± 6.1 | 33.1 ± 5.7 | 0.880 |
BUN (mmol/L) | 5.5 ± 2.2 | 5.0 ± 1.4 | 0.326 |
Bilirubin (mg/dL) | 7.0 ± 2.6 | 8.0 ± 3.5 | 0.233 |
Albumin (g/dL) | 41.7 ± 3.1 | 42.8 ± 3.9 | 0.242 |
Potassium (mmol/L) | 4.2 ± 0.5 | 4.1 ± 0.4 | 0.205 |
Calcium (mmol/L) | 2.3 ± 0.09 | 2.3 ± 0.1 | 0.411 |